Literature DB >> 11527362

Cognitive and motor development in children with vertically transmitted HIV infection.

N Blanchette, M L Smith, A Fernandes-Penney, S King, S Read.   

Abstract

This study was designed to examine mental and motor development in infants with vertically transmitted human immunodeficiency virus (HIV) infection. Early neurodevelopment was examined in 25 young children with HIV infection acquired through vertical transmission. Compared with 25 children born to HIV-positive mothers but not infected with the virus, and after controlling for developmental risk factors, the HIV-infected group showed impairments in mental and motor development. Mental and motor development were assessed using the Bayley Scales of Infant Development. On the mental scale (MDI), the HIV-infected infants obtained significantly lower scores than the uninfected infants. On the performace scale (PDI), the HIV-infected infants obtained significantly lower standard scores than the uninfected infants. CT scan results were available for 20 of the HIV-infected children. CT abnormalities were associated with developmental delays, particularly for motor development. The results point to the importance of early abnormalities in myelination and of subcortical lesions of cognitive and motor development.

Entities:  

Mesh:

Year:  2001        PMID: 11527362     DOI: 10.1016/s0278-2626(01)80032-4

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  18 in total

1.  Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts.

Authors:  Theodore D Ruel; Michael J Boivin; Hannah E Boal; Paul Bangirana; Edwin Charlebois; Diane V Havlir; Philip J Rosenthal; Grant Dorsey; Jane Achan; Carolyne Akello; Moses R Kamya; Joseph K Wong
Journal:  Clin Infect Dis       Date:  2012-02-04       Impact factor: 9.079

2.  Cognition, Emotional Health, and Immunological Markers in Children With Long-Term Nonprogressive HIV.

Authors:  Robert Paul; Tanakorn Apornpong; Wasana Prasitsuebsai; Thanyawee Puthanakit; Vonthanak Saphonn; Linda Aurpibul; Pope Kosalaraksa; Suparat Kanjanavanit; Wicharn Luesomboon; Chaiwat Ngampiyaskul; Tulathip Suwanlerk; Kea Chettra; William T Shearer; Victor Valcour; Jintanat Ananworanich; Stephen Kerr
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

3.  Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children.

Authors:  Heena Brahmbhatt; Michael Boivin; Victor Ssempijja; Joseph Kagaayi; Godfrey Kigozi; David Serwadda; Avy Violari; Ronald H Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

Review 4.  Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?

Authors:  Heather Carryl; Melanie Swang; Jerome Lawrence; Kimberly Curtis; Herman Kamboj; Koen K A Van Rompay; Kristina De Paris; Mark W Burke
Journal:  ACS Chem Neurosci       Date:  2015-06-19       Impact factor: 4.418

5.  Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV.

Authors:  Heena Brahmbhatt; Michael Boivin; Victor Ssempijja; Godfrey Kigozi; Joseph Kagaayi; David Serwadda; Ronald H Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

6.  Neurocognitive functioning in a Romanian cohort of young adults with parenterally-acquired HIV-infection during childhood.

Authors:  Luminita Ene; Donald R Franklin; Ruxandra Burlacu; Anca E Luca; Andreea G Blaglosov; Ronald J Ellis; Terry J Alexander; Anya Umlauf; Igor Grant; Dan C Duiculescu; Cristian L Achim; Thomas D Marcotte
Journal:  J Neurovirol       Date:  2014-09-04       Impact factor: 2.643

7.  Stressful life events and their relationship to psychological and medical functioning in children and adolescents with HIV infection.

Authors:  Deborah K Elliott-DeSorbo; Staci Martin; Pamela L Wolters
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11-01       Impact factor: 3.731

8.  Plasma CXCL10 correlates with HAND in HIV-infected women.

Authors:  R Burlacu; A Umlauf; T D Marcotte; B Soontornniyomkij; C C Diaconu; A Bulacu-Talnariu; A Temereanca; S M Ruta; S Letendre; L Ene; C L Achim
Journal:  J Neurovirol       Date:  2019-08-14       Impact factor: 2.643

Review 9.  HIV-1 proteins, Tat and gp120, target the developing dopamine system.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

Review 10.  The ART of HIV therapies: dopaminergic deficits and future treatments for HIV pediatric encephalopathy.

Authors:  Katy M Webb; Charles F Mactutus; Rosemarie M Booze
Journal:  Expert Rev Anti Infect Ther       Date:  2009-03       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.